2018
DOI: 10.3389/fphar.2018.01454
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Interventions to Improve Long-Term Medication Adherence Across Different Clinical Conditions: A Systematic Review With Network Meta-Analysis

Abstract: Background: Medication non-adherence has a dynamic, temporal and multifactorial nature with a significant impact on economic and clinical outcomes. Interventions to improve adherence are complex and require adaptation to patients' needs, which may include patient's medical conditions. The aim of this study was to assess the comparative effectiveness of medication adherence interventions per type of clinical condition on adult patients.Methods: A systematic review with network meta-analysis was performed (PROSP… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
26
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 29 publications
(27 citation statements)
references
References 49 publications
1
26
0
Order By: Relevance
“…Some interventions tested globally to enhance adherence included simple dose adjustment and reduction of the number of medications (Burke et al, 1997; Schedlbauer et al, 2010), reminders and improved scheduling (Claxton et al, 2001), and educational interventions (Kuntz et al, 2014; Torres-Robles et al, 2018). Other interventions included more comprehensive and complex strategies, such as expansion of the pharmacist role in health care, enhancement of patient–health care provider communication and trust, provision of services (Lu et al, 2008; Banning, 2009), proper description of disease and medications (Osterberg and Blaschke, 2005; Huang et al, 2017), habit analysis and management of side effects (Omran et al, 2012; Conn and Ruppar, 2017), patient follow-up, social and behavioral support and motivation (DiMatteo et al, 2012; Varshney, 2013; Kuntz et al, 2014; Ferdinand et al, 2017), and acting on patients’ feedback (Farris et al, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Some interventions tested globally to enhance adherence included simple dose adjustment and reduction of the number of medications (Burke et al, 1997; Schedlbauer et al, 2010), reminders and improved scheduling (Claxton et al, 2001), and educational interventions (Kuntz et al, 2014; Torres-Robles et al, 2018). Other interventions included more comprehensive and complex strategies, such as expansion of the pharmacist role in health care, enhancement of patient–health care provider communication and trust, provision of services (Lu et al, 2008; Banning, 2009), proper description of disease and medications (Osterberg and Blaschke, 2005; Huang et al, 2017), habit analysis and management of side effects (Omran et al, 2012; Conn and Ruppar, 2017), patient follow-up, social and behavioral support and motivation (DiMatteo et al, 2012; Varshney, 2013; Kuntz et al, 2014; Ferdinand et al, 2017), and acting on patients’ feedback (Farris et al, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Several simple and complex interventions have been tried to improve adherence. Some of the interventions that have been examined have entailed reducing the number of prescribed drugs and adjusting the dose [27,34], giving medication reminders and improving medication schedules [35], and employing educational strategies [8,36,37]. More complex and comprehensive strategies have also been implemented and tested.…”
Section: Introductionmentioning
confidence: 99%
“…This was achieved by evaluating the patterns and changes of the effect of intervention components comprehensively across all clinical conditions over time, by not limiting our research to a clinical condition, a setting or a specific intervention type. Previous research demonstrated that the effectiveness of interventions may be related to the clinical condition [ 13 ]. Although including different clinical conditions in the network meta-analysis may be considered as a drawback due the potential heterogeneity induced, in our research, the four periods of evaluation contain an almost identical mix of medical conditions.…”
Section: Discussionmentioning
confidence: 99%
“…While patient population characteristics may have an effect on adherence, determinants and barriers for non-adherence are often comparable across different medications and clinical conditions. [ 11 13 ].…”
Section: Introductionmentioning
confidence: 99%